Among MAPK, the ERK1/2 pathway, the most evaluated subunit in inflammatory responses, has been determined to play a critical role in the progression and development of IBD and the generation of pro-inflammatory cytokines such as IL-1 and IL-21 [34,35]. Here, MAPK3 is linked to inflammatory bowel disease.